Targeting Cancer Cell Dormancy DOI
Ariadna Recasens, Lenka Munoz

Trends in Pharmacological Sciences, Journal Year: 2019, Volume and Issue: 40(2), P. 128 - 141

Published: Jan. 3, 2019

Language: Английский

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway DOI
Vasanthi S. Viswanathan, Matthew J. Ryan, Harshil Dhruv

et al.

Nature, Journal Year: 2017, Volume and Issue: 547(7664), P. 453 - 457

Published: July 1, 2017

Language: Английский

Citations

1565

Single-cell RNA sequencing technologies and bioinformatics pipelines DOI Creative Commons
Byungjin Hwang, Ji Hyun Lee, Duhee Bang

et al.

Experimental & Molecular Medicine, Journal Year: 2018, Volume and Issue: 50(8), P. 1 - 14

Published: Aug. 1, 2018

Rapid progress in the development of next-generation sequencing (NGS) technologies recent years has provided many valuable insights into complex biological systems, ranging from cancer genomics to diverse microbial communities. NGS-based for genomics, transcriptomics, and epigenomics are now increasingly focused on characterization individual cells. These single-cell analyses will allow researchers uncover new potentially unexpected discoveries relative traditional profiling methods that assess bulk populations. Single-cell RNA (scRNA-seq), example, can reveal rare cell populations, regulatory relationships between genes, track trajectories distinct lineages development. In this review, we focus technical challenges isolation library preparation computational analysis pipelines available analyzing scRNA-seq data. Further improvements at level molecular biology bioinformatics tools greatly facilitate both basic science medical applications these technologies. Showing which genes expressed, or switched on, cells may help first signs disease. Each an organism contains same genetic information, but type behavior depend expressed. Previously, could only sequence batches, averaging results, technological expressed cell, known as (scRNA-seq). Ji Hyun Lee (Kyung Hee University, Seoul) Duhee Bang Byungjin Hwang (Yonsei have reviewed strategies analyze large quantities data produced. They conclude impact science, illuminating drug resistance revealing pathways differentiation during

Language: Английский

Citations

1555

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition DOI
Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan

et al.

Nature, Journal Year: 2017, Volume and Issue: 551(7679), P. 247 - 250

Published: Oct. 31, 2017

Language: Английский

Citations

1352

YAP/TAZ upstream signals and downstream responses DOI
Antonio Totaro, Tito Panciera, Stefano Piccolo

et al.

Nature Cell Biology, Journal Year: 2018, Volume and Issue: 20(8), P. 888 - 899

Published: July 19, 2018

Language: Английский

Citations

828

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress DOI Creative Commons
Jennifer Tsoi,

Lídia Robert,

Kim H.T. Paraiso

et al.

Cancer Cell, Journal Year: 2018, Volume and Issue: 33(5), P. 890 - 904.e5

Published: April 12, 2018

Language: Английский

Citations

800

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance DOI Creative Commons
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák

et al.

Cancer Cell, Journal Year: 2020, Volume and Issue: 37(4), P. 471 - 484

Published: April 1, 2020

Language: Английский

Citations

725

SAVER: gene expression recovery for single-cell RNA sequencing DOI
Mo Huang, Jingshu Wang, Eduardo A. Torre

et al.

Nature Methods, Journal Year: 2018, Volume and Issue: 15(7), P. 539 - 542

Published: June 22, 2018

Language: Английский

Citations

695

Toward Minimal Residual Disease-Directed Therapy in Melanoma DOI Creative Commons
Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar

et al.

Cell, Journal Year: 2018, Volume and Issue: 174(4), P. 843 - 855.e19

Published: July 13, 2018

Language: Английский

Citations

637

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity DOI Open Access
Shannon Lee, Jens Rauch, Walter Kölch

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(3), P. 1102 - 1102

Published: Feb. 7, 2020

Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous signal transduction that regulate all aspects of life and are frequently altered in disease. Here, we focus on the role MAPK modulating drug sensitivity resistance cancer. We briefly discuss new findings extracellular signaling-regulated (ERK) pathway, but mainly mechanisms how stress activated pathways, such as p38 Jun N-terminal kinases (JNK), impact response cancer cells to chemotherapies targeted therapies. In this context, also metabolic epigenetic aberrations therapeutic opportunities arising from these changes.

Language: Английский

Citations

637

The great escape: tumour cell plasticity in resistance to targeted therapy DOI

Soufiane Boumahdi,

Frédéric J. de Sauvage

Nature Reviews Drug Discovery, Journal Year: 2019, Volume and Issue: 19(1), P. 39 - 56

Published: Oct. 10, 2019

Language: Английский

Citations

603